HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macrophage activation syndrome revealing disseminated tuberculosis in a patient on infliximab.

AuthorsVincent André, Charly Liddell, Thomas Guimard, Gilles Tanguy, Grégoire Cormier
JournalJoint bone spine (Joint Bone Spine) Vol. 80 Issue 1 Pg. 109-10 (Jan 2013) ISSN: 1778-7254 [Electronic] France
PMID23286892 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Arthritis, Psoriatic (drug therapy)
  • Fatal Outcome
  • Humans
  • Infliximab
  • Macrophage Activation Syndrome (etiology)
  • Male
  • Tuberculosis (diagnosis, etiology)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: